Roche Holding | ROG - Gross Profit On Sales

Stock Price
358.70
Daily Change
-1.90 -0.53%
Monthly
8.73%
Yearly
24.68%
Q1 Forecast
342.18

Roche Holding reported CHF22.09B in Gross Profit on Sales for its fiscal semester ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Alcon AG USD 1.46B 70M Sep/2025
Amgen USD 6.48B 307M Sep/2025
AstraZeneca USD 12.39B 406M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Biogen USD 1.68B 358.6M Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Fresenius EUR 1.3B 158M Sep/2025
Fresenius Medical Care EUR 1.24B 27M Sep/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 868M 195M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.21B 186M Sep/2025
Merck USD 13.42B 431M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Orion EUR 254.2M 5.9M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Philips EUR 1.91B 100M Sep/2025
Recordati EUR 423.85M 34.92M Jun/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 2.46B 520M Dec/2024